Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Everolimus Arrow 2.5mg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Everolimus Arrow 2.5mg :
Type Medicine Authorised
Originator G
Agent Darapharma
Distributor Darapharma
Laboratory Arrow Génériques
Responsible Party Arrow Génériques
Origin France
Manufacturer Ethypharm SA
Manufacturing Type G
Origin France
ATC L01XE10

Your comment will appear shortly after approval

Everolimus Arrow 2.5mg :

Revision Date : 16/12/2014


Effect Frequency
Abdominal pain Common
Acne Common
Acute respiratory distress syndrome Rare
Ageusia (Taste loss) Uncommon
Alopecia Common
ALT increased Common
Alveolitis Rare
Amenorrhoea secondary Uncommon
Anaemia Very Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Aphthous stomatitis Common
Aplasia pure red cell (PRCA) Rare
Arthralgia (Pain joint) (Joint ache) Common
Aspergillosis Not known
AST increased Common
Asthenia Very Common
Blood creatinine increased Common
Candidiasis (Candida infection) Not known
Congestive heart failure Uncommon
Conjunctivitis Uncommon
Cough Common
Decreased appetite Very Common
Deep vein thrombosis Uncommon
Dehydration Common
Diabetes mellitus Common
Diarrhoea (Diarrhea) Very Common
Dry mouth (Xerostomia) Common
Dry skin Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Common
Dysphagia Common
Dyspnoea (dyspnea) Common
Epistaxis (Nasal bleeding) Very Common
Erythema Common
Eyelid oedema Common
Fatigue Very Common
Flushing Uncommon
Glossitis Uncommon
Glossodynia Uncommon
Haemoptysis Uncommon
Haemorrhage Common
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Common
Headache Very Common
Hepatitis B reactivation Not known
Herpes zoster Uncommon
Hypercholesterolaemia Very Common
Hyperglycaemia Very Common
Hyperlipidaemia Common
Hypersensitivity Uncommon
Hypertension Common
Hypertriglyceridaemia Common
Hypocalcaemia Common
Hypokalaemia Common
Hypophosphataemia Common
Infection Very Common
Insomnia Common
Interstitial pneumonitis Common
Leucopenia (Leukopenia) Common
Lung infiltration (pulmonary infiltration) Common
Lymphopenia Common
Menstruation irregular Common
Mouth ulceration Common
Mucosal inflammation Common
Nail disorders Common
Nausea Very Common
Neutropenia Common
Non-cardiac chest pain Uncommon
Oedema peripheral Very Common
Onychoclasis Common
Opportunistic infections Not known
Oral pain Common
Pancytopenia Uncommon
Pneumocystis carinii pneumonia Not known
Pneumonia Common
Pneumonitis Very Common
Proteinuria Common
Pruritus Very Common
Pulmonary alveolar haemorrhage Rare
Pulmonary embolism Uncommon
Pulmonary toxicity Rare
Pyrexia Common
Renal failure Common
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Uncommon
Sepsis (Systemic infection) (Sepsis state) Uncommon
Skin exfoliation (Flaking skin) Common
Skin lesion Common
Skin rash Very Common
Stomatitis Very Common
Thrombocytopenia (Thrombopenia) Common
Tongue ulceration Common
Urine output increased Uncommon
Vomiting Common
Weight decreased (Weight loss) Very Common
Wound healing delayed Rare

Different Units By MoH Code

Revision Date : 20/09/2022

Revision Date : 20/09/2022

Everolimus Arrow 2.5mg  MoH 10481 :
Form Tablet
Packaging Blisters (PA/Al/PVC/Al)
Package Size Box of 30
Strength 2.5mg
Storage Condition <25°C protect from light
Public Price 885246 L.L.
Stratum E1
NSSF ✘
Quarantine ✘
Reg. Number 2220/1
Submission date 02/01/2020
Registration Year 14/10/2020


Price Comparison

● Country: France
● Package Size: 30
● Public Price: 511.54 EUR ( 49,555,949.04 LBP )
● Pack size unit used: 30
● Cost/Unit: 17,0513 EUR ( 1,646,892.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 30
● Public Price: 885246 LBP ( 885,246.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 29508,2 LBP ( 29,508.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 17,0513 EUR ( 1,646,892.00 LBP )
● Cost/Day: 68,21 EUR ( 6,587,568.00 LBP )
● Cost/Month: 2046,3 EUR ( 198,208,296.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 17,0513 EUR ( 1,646,892.00 LBP )
● Cost/Day: 68,21 EUR ( 6,587,568.00 LBP )
● Cost/Month: 2046,3 EUR ( 198,208,296.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 29508,2 LBP ( 29,508.00 LBP )
● Cost/Day: 118032,8 LBP ( 118,032.00 LBP )
● Cost/Month: 3540984 LBP ( 3,540,984.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 29508,2 LBP ( 29,508.00 LBP )
● Cost/Day: 118032,8 LBP ( 118,032.00 LBP )
● Cost/Month: 3540984 LBP ( 3,540,984.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info